返回 Agenda
Modernizing Clinical Trials: How New Approaches and CRO Partnerships Accelerate Safe, Effective Drug Development
Session Chair(s)
Cynthia L. Verst, PharmD, MS
President, R&D Solutions D&DI; 2023 President, IQVIA, United States
Robert Goodwin, MBA, MSc
Chief Operating Officer, Parexel, United States
Jay Roberts, MBA
Partner, Ventac Partners, United States
Catherine Gregor, MA, MBA
Chief Clinical Trial Officer, Florence Healthcare, United States
Ildefonso Rodriquez-Rivera
Clinical Investigator, NextOncology, United States
One of the most time consuming and costly parts of developing new drugs is the conduct of clinical trials. The goals of clinical trials are to test the safety and efficacy of new drugs in human populations. Clinical trials have to follow strict guidelines approved by the regulatory agencies. It is also important to choose the right group of patients from around the world, recruit them in an efficient manner and complete the trials on time and help with preparing the documents necessary for review and approval. There are many clinical research organizations (CRO’s) around the world that help with all aspects of clinical trials. Gain insights on considerations for selecting and working with CROs from the investor, biotech, as well as the CRO perspective.